4.7 Article

Long-term effects of GH therapy in adult patients with Prader-Willi syndrome: a longitudinal study

Related references

Note: Only part of the references are listed.
Review Genetics & Heredity

The consequences of hyperphagia in people with Prader-Willi Syndrome: A systematic review of studies of morbidity and mortality

S. A. Bellis et al.

Summary: Prader-Willi Syndrome (PWS) is a genetically determined neurodevelopmental disorder that commonly leads to syndromal obesity. Research shows that aside from obesity, hyperphagia itself is a significant factor contributing to morbidity and mortality. Improving life expectancy depends on managing the immediate consequences of hyperphagia, both non-obesity related and obesity-related.

EUROPEAN JOURNAL OF MEDICAL GENETICS (2022)

Review Endocrinology & Metabolism

The use of growth hormone therapy in adults with Prader-Willi syndrome: A systematic review

Mikaela Frixou et al.

Summary: The role of growth hormone in adults with Prader-Willi syndrome remains unclear, with mixed effects on body composition, bone health, and cardiovascular health. While GH therapy appears safe and well-tolerated, further longitudinal studies are needed to explore its effects on bone and cardiovascular health.

CLINICAL ENDOCRINOLOGY (2021)

Letter Genetics & Heredity

Time for a general approval of growth hormone treatment in adults with Prader-Willi syndrome

Charlotte Hoeybye et al.

Summary: Prader-Willi syndrome is a complex neurodevelopmental disorder characterized by a range of physical and intellectual disabilities. Growth hormone treatment has been shown to have positive effects on body composition, normalizing height, and improving quality of life in both children and adults with PWS. There is a need for international approval of GH treatment for adults with genetically confirmed PWS.

ORPHANET JOURNAL OF RARE DISEASES (2021)

Review Endocrinology & Metabolism

Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction

Maithe Tauber et al.

Summary: Prader-Willi syndrome is a rare genetic neurodevelopmental disorder characterized by impaired hypothalamic development and function, leading to a range of phenotypes from anorexia to obesity. Endocrine dysfunctions, including growth hormone deficiency and hormonal imbalances, are commonly observed in patients with this syndrome, requiring hormone replacement therapy for management.

LANCET DIABETES & ENDOCRINOLOGY (2021)

Article Endocrinology & Metabolism

Growth Hormone Treatment for Adults With Prader-Willi Syndrome: A Meta-Analysis

Anna G. W. Rosenberg et al.

Summary: GHt treatment improves body composition in adults with PWS, with no major safety issues, although it has limited impact on BMI and bone density.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Medicine, General & Internal

Twenty Years of GH Treatment in Adults with Prader-Willi Syndrome

Anna Sjostrom et al.

Summary: Prader-Willi syndrome is a rare neurodevelopmental genetic disorder characterized by specific physical and cognitive symptoms. A study on long-term growth hormone (GH) treatment in adult patients with PWS found that it did not adversely affect body composition and metabolism, indicating its safety in this population.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Pediatrics

Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysis

Caroline de Gouveia Buff Passone et al.

BMJ PAEDIATRICS OPEN (2020)

Article Genetics & Heredity

Molecular genetic classification in Prader-Willi syndrome: a multisite cohort study

Merlin G. Butler et al.

JOURNAL OF MEDICAL GENETICS (2019)

Review Endocrinology & Metabolism

Prader- Willi syndrome: An uptodate on endocrine and metabolic complications

Giovanna Muscogiuri et al.

REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2019)

Article Genetics & Heredity

Causes of death in Prader-Willi syndrome: lessons from 11 years' experience of a national reference center

Dibia Liz Pacoricona Alfaro et al.

ORPHANET JOURNAL OF RARE DISEASES (2019)

Article Genetics & Heredity

Contributing factors of mortality in Prader-Willi syndrome

Jennifer Proffitt et al.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2019)

Article Endocrinology & Metabolism

Diagnosis and treatment of GH deficiency in Prader-Willi syndrome

Graziano Grugni et al.

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2016)

Article Endocrinology & Metabolism

Reference Values for IGF-I Serum Concentrations: Comparison of Six Immunoassays

Philippe Chanson et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)

Article Cardiac & Cardiovascular Systems

Disorders of glucose metabolism in Prader-Willi syndrome: Results of a multicenter Italian cohort study

D. Fintini et al.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2016)

Review Health Care Sciences & Services

Growth hormone therapy for Prader-Willi syndrome: challenges and solutions

Graziano Grugni et al.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2016)

Article Endocrinology & Metabolism

Metabolic and Adipose Tissue Signatures in Adults With Prader-Willi Syndrome: A Model of Extreme Adiposity

Delphine Lacroix et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)

Article Endocrinology & Metabolism

Does segmental body composition differ in women with Prader-Willi syndrome compared to women with essential obesity?

G. Bedogni et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2015)

Review Endocrinology & Metabolism

Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings

M. A. Angulo et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2015)

Article Endocrinology & Metabolism

Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome

Cheri L. Deal et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)

Article Endocrinology & Metabolism

Effects of recombinant human growth hormone therapy in adults with Prader-Willi syndrome: a meta-analysis

Ruth Sanchez-Ortiga et al.

CLINICAL ENDOCRINOLOGY (2012)

Article Endocrinology & Metabolism

Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline

Mark E. Molitch et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)

Article Endocrinology & Metabolism

Body composition and fatness patterns in Prader-Willi syndrome: Comparison with simple obesity

Mariana F. Theodoro et al.

OBESITY (2006)

Review Public, Environmental & Occupational Health

What aspects of body fat are particularly hazardous and how do we measure them?

MB Snijder et al.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2006)

Article Endocrinology & Metabolism

The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index

G Corneli et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)